Evotec SE (LTS:0IRF) 5-Year Yield-on-Cost % : 0.00 (As of May. 17, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Evotec SE 5-Year Yield-on-Cost %?

Evotec SE's yield on cost for the quarter that ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Evotec SE's 5-Year Yield-on-Cost % or its related term are showing as below:

LTS:0IRF's 5-Year Yield-on-Cost % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.04
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Evotec SE's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evotec SE's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Evotec SE's 5-Year Yield-on-Cost % falls into.

Evotec SE 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Evotec SE is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Evotec SE (LTS:0IRF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Evotec SE 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Evotec SE's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE (LTS:0IRF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (LTS:0IRF) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

EVO:USA EVOTF:USA 1EVT:Italy EVTd:UK EVT:Germany EVT:Austria

Address

Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419

Website

https://www.evotec.com

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Evotec SE (LTS:0IRF) Headlines

No Headlines